Literature DB >> 4106379

Antibody against serum-hepatitis antigen. Prevalence and potential use as immune serum globulin in prevention of serum-hepatitis infections.

A M Prince, W Szmuness, K R Woods, G F Grady.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1971        PMID: 4106379     DOI: 10.1056/NEJM197110212851702

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  9 in total

1.  High affinity mouse-human chimeric Fab against hepatitis B surface antigen.

Authors:  Biplab Bose; Navin Khanna; Subrat K Acharya; Subrata Sinha
Journal:  World J Gastroenterol       Date:  2005-12-28       Impact factor: 5.742

2.  Generation and characterization of high affinity humanized fab against hepatitis B surface antigen.

Authors:  Ashutosh Tiwari; Durgashree Dutta; Navin Khanna; Subrat K Acharya; Subrata Sinha
Journal:  Mol Biotechnol       Date:  2009-03-27       Impact factor: 2.695

3.  Fulminant hepatitis-virus B in a three months old infant: therapeutic trial with specific anti-HB globulins in antibody excess.

Authors:  J M Dupuy; J L Virelizier; D Frommel
Journal:  Infection       Date:  1973       Impact factor: 3.553

Review 4.  Long-incubation (virus B, HAA-associated) hepatitis.

Authors:  S Sherlock
Journal:  Gut       Date:  1972-04       Impact factor: 23.059

5.  Interactions of standard antibody with Australia antigens in Au Ag-Ab radioimmunoassay.

Authors:  H Daugharty; R G Young; M H Hatch; D W Ziegler
Journal:  Appl Microbiol       Date:  1974-04

6.  An automated passive haemagglutination technique suitable for the detection of hepatitis B virus antigen and antibody in blood donors.

Authors:  M Nelson; E J Phipps; P G Watson; J R Watts; R Zwolenski
Journal:  J Clin Pathol       Date:  1973-05       Impact factor: 3.411

7.  Viral hepatitis and hepatitis B antigen: recent advances.

Authors:  S Krugman
Journal:  Postgrad Med J       Date:  1974-06       Impact factor: 2.401

8.  Hepatitis B virus vaccine: identification of HBsAg/a and HBsAg/d but not HBsAg/y subtype antigenic determinants on a synthetic immunogenic peptide.

Authors:  A M Prince; H Ikram; T P Hopp
Journal:  Proc Natl Acad Sci U S A       Date:  1982-01       Impact factor: 11.205

Review 9.  Antiviral therapy.

Authors:  H Stalder
Journal:  Yale J Biol Med       Date:  1977 Sep-Oct
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.